2000 Participants Needed

Social Determinants for Bone Marrow Transplant

WF
Overseen ByWarren Fingrut, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to explore how social and financial factors affect the outcomes of transplant and cell therapy (TCT) treatments. Researchers seek to understand the impact of issues like language barriers, education level, and employment history on patient care. The trial is open to individuals receiving TCT at MD Anderson who encounter social or financial challenges. Participants will share their experiences through interviews to help identify barriers to effective treatment.

As an unphased trial, this study offers participants the chance to contribute to valuable research that could enhance patient care for those facing similar challenges.

Do I have to stop taking my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It focuses on social and financial factors, so it's best to ask the trial coordinators for more details.

Why are researchers excited about this trial?

Researchers are excited about this trial because it focuses on understanding how social determinants of health impact transplant and cell therapy outcomes. Unlike traditional approaches that mainly emphasize medical and biological factors, this study digs into social aspects like language barriers, education, and caregiver support. By identifying these barriers, the trial aims to improve patient care and outcomes in a way that existing treatments don't fully address. This holistic perspective could lead to more personalized and effective healthcare strategies for transplant and cell therapy patients.

Who Is on the Research Team?

WF

Warren Fingrut, MD

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

Inclusion Criteria

My caregiver is willing to do an interview.
I am a patient interested in a qualitative study.
I have financial approval for my treatment.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Data Collection

Participants' demographic information and social determinants of health are assessed

4 weeks
1 visit (in-person)

Follow-up

Participants are monitored for outcomes related to social determinants of health after transplantation and cell therapy

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Social Determinants of Health Questionnaire

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Transplant and Cell Therapy Candidates and RecipientsExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+